Cancer News and Research

Latest Cancer News and Research

Researchers elucidate the effect of nutritional parameters in long-term PPI therapy

Gastroesophageal reflux disease (GERD) is the most common esophageal disorder, and frequently encountered in the primary care setting. Accumulating evidence has confirmed the excellent efficacy and safety of proton pump inhibitor (PPI) therapy in patients with all grades of GERD, making these agents the mainstay of treatment.

24 Oct 2009

Race to raise awareness about breast cancer at the Pyramids of Giza

Egypt’s breast cancer movement will race forward at the historic Pyramids of Giza today. A mighty gathering of Egyptians and international visitors will run and walk across the Pyramids site starting at 10 a.m. to raise awareness about breast cancer during the first Race for the Cure® in the Middle East, organized by Susan G. Komen for the Cure® and the Breast Cancer Foundation of Egypt under the auspices of the First Lady of Egypt, H.E. Mrs. Suzanne Mubarak.

24 Oct 2009

Naviscan to present clinical trail results of new tools for breast cancer treatment

Naviscan, Inc., the leader in Molecular Breast Imaging (MBI), today announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.

24 Oct 2009

New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved

Health Canada has approved a new nucleic acid test from Roche Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay.

From Roche Sequencing and Life Science 24 Oct 2009

FDA issues emergency use authorization for peramivir anti-viral drug

BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

24 Oct 2009

Emodin raises hope for treatment of fibrotic liver diseases

In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.

24 Oct 2009

Study on Pten's tumour suppressive functions published

Sanford Barsky, M.D., who holds faculty positions at the University of Nevada School of Medicine as chair of the pathology department and Nevada Cancer Institute chief of pathology, is part of a team that has a paper on transgenic mouse mammary tumors with direct relevance to human breast cancer published in the October 22 issue of the scientific journal Nature.

24 Oct 2009

IMRIS sells IMRISNV to Connecticut-based Yale-New Haven Hospital

IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISNV to Connecticut-based Yale-New Haven Hospital (the "Hospital"), the primary teaching hospital for the Yale School of Medicine.

24 Oct 2009

Biomoda to complete Phase II clinical trial of Biomoda assay for lung cancer detection

Biomoda, Inc., a diagnostics company focused on the development of accurate, inexpensive and noninvasive in-vitro tests for the early detection of cancer, has met its recruitment goal for New Mexico veterans with a history of heavy smoking required to complete the Phase II clinical trial of Biomoda's early-stage diagnostic for lung cancer.

24 Oct 2009

Report on health insurance reform to support women with breast cancer

As Americans mark breast cancer awareness month, Secretary of Health and Human Services Kathleen Sebelius today released a new report, Health Insurance Reform and Breast Cancer: Making the Health Care System Work for Women.

24 Oct 2009

Curriculum to increase science literacy and generate enthusiasm for life sciences among high school students

A new curriculum called The Great Diseases will bring real-world biomedical research to students in three Boston high schools. The result of a collaboration between scientists from Tufts University School of Medicine and teachers from the Boston Public Schools, the curriculum presents current threats to global health through laboratory learning, multimedia, and case-based studies

24 Oct 2009

Seventh Generation partners with Erin Brockovich and Safer Chemicals to launch Million Baby Crawl

Seventh Generation, the nation's leading brand of non-toxic and environmentally-safe household and personal care products, announced today a new partnership with noted advocate Erin Brockovich and Safer Chemicals, Healthy Families.

24 Oct 2009

National campaign to raise awareness of actinic keratosis

Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) -- a potential early warning sign of skin cancer -- as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.

24 Oct 2009

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

The Patient Advocate Foundation (PAF) -- a national non-profit organization providing patient services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials -- is pleased to announce that PAF Executive Board Member Venus Gines, founder and CEO of Dia de la Mujer Latina(TM) Inc (Day of the Latin American Woman), provided first-hand testimony today to First Lady Michelle Obama regarding her own and other patients' experiences in being denied health insurance due to pre-existing conditions, and the need to protect patients against such discrimination under healthcare reform.

24 Oct 2009

Researchers find link between hepatic steatosis and carotid lesions

Nonalcoholic fatty liver disease (NAFLD) is often caused by abdominal obesity, which is also one of the main causes of insulin resistance and metabolic syndrome. The latter, in turn, is an important cardiovascular risk factor, and has been found to be associated with the presence of carotid atherosclerotic lesions.

24 Oct 2009

NCI and NIOH to purchase additional MammoView line of surgical endoscopy instruments

Solos Endoscopy, Inc. is pleased to announce that the Company has received additional purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI), as well as the U.S. National Institute of Health (NIOH), which is part of the U.S. Department of Health and Human Services.

24 Oct 2009

CAP commends SACGHS stand against human health-related gene patents

The College of American Pathologists today expressed its support for a key government advisory group's recommendation to create an exemption from liability for infringement of gene patent claims when used for patient care purposes.

24 Oct 2009

New trends in hospital design help health-care systems to better choreograph care

Heading to the hospital? These days, the newest member of your medical team just might be the building itself -- and it's likely to play a bigger role in your healing than you might think.

24 Oct 2009

Rocawear joins Susan G. Komen for the Cure movement in reclaiming women from breast cancer

ROCAWEAR LENDS SUPPORT IN RECLAIMING WOMEN FROM BREAST CANCER. From October 1 through December 31, 2009 Rocawear will donate 5% of the retail price of its special edition Roc for the Cause Polo to Susan G. Komen for the Cure® Circle of Promise with a minimum guaranteed donation of $20,000.

24 Oct 2009

Elekta to demonstrate stereotactic solutions at the 2009 CNS Annual Meeting

At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.

From Elekta 24 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Researchers elucidate the effect of nutritional parameters in long-term PPI therapy

Race to raise awareness about breast cancer at the Pyramids of Giza

Naviscan to present clinical trail results of new tools for breast cancer treatment

New nucleic acid test to screen donated blood for HIV-1 Group M RNA approved

FDA issues emergency use authorization for peramivir anti-viral drug

Emodin raises hope for treatment of fibrotic liver diseases

Study on Pten's tumour suppressive functions published

IMRIS sells IMRISNV to Connecticut-based Yale-New Haven Hospital

Biomoda to complete Phase II clinical trial of Biomoda assay for lung cancer detection

Report on health insurance reform to support women with breast cancer

Curriculum to increase science literacy and generate enthusiasm for life sciences among high school students

Seventh Generation partners with Erin Brockovich and Safer Chemicals to launch Million Baby Crawl

National campaign to raise awareness of actinic keratosis

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

Researchers find link between hepatic steatosis and carotid lesions

NCI and NIOH to purchase additional MammoView line of surgical endoscopy instruments

CAP commends SACGHS stand against human health-related gene patents

New trends in hospital design help health-care systems to better choreograph care

Rocawear joins Susan G. Komen for the Cure movement in reclaiming women from breast cancer

Elekta to demonstrate stereotactic solutions at the 2009 CNS Annual Meeting

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in